- 全部删除
 
您的购物车当前为空
O-1602 是一种新型 GPR55 激动剂,是一种非典型大麻素,与中枢神经系统和肥胖有关,是治疗膀胱炎的候选化合物。O-1602通过小鼠GPR55 的 PI3激酶/ Akt / SREBP-1c信号传导促进肝脂肪变性。O-1602以GPR3非依赖性方式诱导Hep55B细胞中的细胞内钙升高。


为众多的药物研发团队赋能,
让新药发现更简单!
O-1602 是一种新型 GPR55 激动剂,是一种非典型大麻素,与中枢神经系统和肥胖有关,是治疗膀胱炎的候选化合物。O-1602通过小鼠GPR55 的 PI3激酶/ Akt / SREBP-1c信号传导促进肝脂肪变性。O-1602以GPR3非依赖性方式诱导Hep55B细胞中的细胞内钙升高。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 410  | In stock | |
| 5 mg | ¥ 993  | In stock | |
| 10 mg | ¥ 1,450  | In stock | |
| 25 mg | ¥ 2,880  | In stock | |
| 50 mg | ¥ 3,970  | In stock | |
| 100 mg | ¥ 5,790  | In stock | |
| 200 mg | ¥ 7,820  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,090  | In stock | 
O-1602 相关产品
| 产品描述 | O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.  | 
| 别名 | O1602, O 1602 | 
| 分子量 | 258.36 | 
| 分子式 | C17H22O2 | 
| CAS No. | 317321-41-8 | 
| Smiles | CC1=C(C(O)=CC(O)=C1)[C@H]2[C@H](C(C)=C)CCC(C)=C2 | 
| 密度 | 1.073 g/cm3 (Predicted) | 
| 颜色 | Yellow | 
| 物理性状 | Oil | 
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25.84 mg/mL (100.02 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.74 mM), Sonication is recommended.  请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容